Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study

Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study

PurposeWe aimed to ascertain the effectiveness of gonadotropin-releasing hormone (GnRH) agonist co-therapy for the preservation of ovarian function in patients with ovarian malignancy who underwent unilateral salpingo-oophorectomy and platinum-based chemotherapy.MethodsWe enrolled 158 patients with...

Full description

Bibliographic Details
Main Authors: Ya Xie, Haoran Duan, Dong Wang, Huiqing Li, Jia Jia, Jialin Zhang, Linlin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
ovarian function
platinum-based chemotherapy
gonadotropin-releasing hormone agonist
ovarian malignancy
anti-Müllerian hormone (AMH)
prospective study
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.986208/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.986208/full

Similar Items